Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Fatty liver disease, a growing concern, affects one in three adults globally. Simple dietary errors like consuming excess ...

Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver ...

In this article, we will share our expert’s insights on whether intermittent fasting is a wise choice for those living with ...

Plainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first and ...

Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form ...

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...

Fingernails reflect internal health. Changes in nail color or texture may signal health problems. Pale nails may indicate ...

Discover the critical insights from top liver specialist Dr. Saurabh Sethi on liver health, revealing facts about liver ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Ian "Big E" Berger has been a Miami Dolphins fans for 40 years, but he is fighting a life-threatening liver condition.